While distributions of EFS and OS were not significantly different between Regimens A and B for patients with medulloblastoma and sPNET , DI chemotherapy resulted in significantly improved EFS distribution ( P = .0011 ) ( 2-year EFS rates of 42.1 % vs. 19.6 % with SD chemotherapy ) , but not OS distribution , for patients with centrally confirmed ependymoma .